Abstract
(−)-Nicotine tartrate (2 mg/kg), and a nicotinic agonist, RJR 2403 (1.4 mg/kg), and antagonist, mecamylamine (1 mg/kg), were administered to separate groups of rats SC twice daily for 10 days. Two other groups received the same doses of nicotine or RJR 2403 for 1 day followed by saline for 9 days. Twenty-four hours after the final injection, the rats were compared to a 10-day saline-injected group on acquisition of a hidden platform position in the Morris water maze (20 trials, 30-min inter-trial interval). The rats were killed 48 h after the last drug injection and frontal, entorhinal and posterior cingulate cortex and dorsal and ventral hippocampus assayed for [3H]-nicotine binding density. Chronic nicotine significantly increased the number of frontal and entorhinal cortical and dorsal hippocampal, but not posterior cingulate cortical or ventral hippocampal, nicotinic receptors, and improved rate of learning. Chronic mecamylamine and RJR 2403 also significantly increased the number of nicotinic receptors in frontal cortex, though not other regions, but retarded rate of learning. Nicotine given for 1 day 11 days earlier marginally increased nicotinic receptors in entorhinal cortex (but not other regions) and significantly increased rate of learning, though significantly less than 10-day nicotine. Entorhinal cortical and dorsal hippocampal nicotinic receptor numbers were positively associated with rate of learning but not performance at asymptote. Thus cognitive enhancement after chronic nicotine is in part a delayed consequence of nicotine administration 11 days earlier, and may reflect regional changes in nicotinic receptor up-regulation.
Similar content being viewed by others
References
Abdulla FA, Calaminici M-R, Gray JA, Sinden JD, Stephenson JD (1992) Sensorimotor neglect and impaired spatial performance in rats after unilateral lesion of the nucleus basalis with α-amino-3-OH-4-isoxozole propionic acid (AMPA). 8th International Cholinergic Symposium: cholinergic neurotransmission: function and dysfunction. Montreal, P71, 68
Abdulla FA, Calaminici M-R, Mitchell SN, Sinden JD, Stephenson JD (1993a) Chronic nicotine treatment and unilateral lesion of nucleus basalis with α-amino-3-OH-4-isoxozole propionic acid (AMPA) alter rat frontal cortex pyramidal cell sensitivity to nicotine. Br J Pharmacol 109 [Suppl.]:32P
Abdulla FA, Calaminici M-R, Stephenson JD, Sinden JD (1993b) Chronic treatment with cholinoceptor drugs influences spatial learning in rats. Psychopharmacology 111:508–511
Abdulla FA, Calaminici M, Wonnacott S, Gray JA, Sinden JD Stephenson JD (1995) Sensitivity of rat frontal cortical neurones to nicotine is increased by chronic administration of nicotine and by lesions of the nucleus basalis magnocellularis: comparison with numbers of [3H]-nicotine binding sites. Synapse 21:281–288
Beatty W, Butters N, Janowsky D (1986) Memory failure after scopolamine treatment: implications for cholinergic hypothesis of dementia. Behav Neural Biol 45:196–211
Brazell MP, Mitchell SN, Gray JA (1990) Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose-response and antagonist study. Neuropharmacolog 30:823–833
Brioni JD, Arneric SP (1993) Nicotine receptor agonists facilitate retention of avoidance training: participation of dopaminergic mechanisms. Behav Neural Biol 59:57–62
Collins AC, Bhat RV, Pauly JR, Marks MJ (1990) Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. In: Bock G, Marsh J (eds) The biology of nicotine dependence. Wiley, Chichester, pp 68–82
Dunnett SB, Toniolo G, Fine A, Ryan CN, Björklund A, Iversen SD (1985) Transplantation of embryonic ventral forebrain neurones to the nucleus basalis magnocellularis — II. Sensorimotor and learning impairments. Neuroscience 16:787–797
Eagger SA, Levy R, Sahakian BJ (1991) Tacrine in Alzheimer's disease. Lancet 337:989–992
Flores CM, Rogers SW, Pabreza LA, Wolfe B, Kellar KJ (1992) A subtype of nicotinic cholinergic receptor is composed ofα 4 andβ 2 subunits and is upregulated by chronic nicotine treatment. Mol Pharmacol 41:31–37
Grady S, Marks MJ, Wonnacott S, Collins AC (1992) Characterization of nicotinic receptor-mediated [3H]-dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848–856
Gray JA, Mitchell SN, Joseph MH, Grigoryan GA, Dawe S, Hodges H (1994) Neurochemical mechanisms mediating the behavioural and cognitive effects of nicotine. Drug Dev Res 31:3–17
Grigoryan GA, Gray JA (1996) A single dose of nicotine proactively enhances the partial reinforcement extinction effect in the rat. Psychobiology (in press)
Hodges H, Allen Y, Sinden J, Lantos PL, Gray JA (1991) Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system-II. Cholinergic drugs as probes to investigate lesion-induced deficits and transplant-induced functional recovery. Neuroscience 45:609–623
Hodges H, Sinden J, Turner JJ, Netto CA, Sowinski P, Gray JA (1992) Nicotine as a tool to characterise the role of the forebrain cholinergic projection system in cognition. In: Lippiello PM, Collins AC, Gray JA, Robinson JH (eds) The biology of nicotine. Raven, New York, pp 157–180
Houston JP, Schneider NG, Jarvik ME (1978) Effects of smoking on free recall and organization. Am J Psychiatry 135:220–222
Jones GMM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108:485–494
Ksir CJ, Hakan RL, Hall J, Kellar K (1985) Nicotine exposure enhances behavioural stimulant effect of nicotine and increases [3H]-acetylcholine binding to nicotinic receptors. Neuropharmacology 24:527–532
Lapchak PA, Araujo DM, Quirion R, Collier B (1989) Effects of chronic nicotine treatment on nicotine autoreceptor function andN-[3H]-methylcarbamylcholine binding sites in the rat brain. J Neurochem 52:483–491
Levin ED (1992) Nicotine systems and cognitive function. Psychopharmacology 108:417–431
Lippiello PM, Fernandes KG (1986) The binding ofl-[3H]-nicotine to a single class of high affinity sites in rat brain membrane. Mol Pharmacol 29:448–454
Marks MJ, Burch JB, Collins AC (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 226:817–825
Marks MJ, Grady SR, Collins AC (1993) Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther 266:1268–1276
Miller RP, Rotenberg KS, Adir J (1977) Effect of dose on the pharmacokinetics of intravenous nicotine in the rat. Drug Metab Dispos 5:436–443
Mitchell SN, Brazell MP, Joseph MH, Alavijeh MS, Gray JA (1989) Regionally specific effects of acute and chronic nicotine on rates of catecholamine and indoleamine synthesis in rat brain. Eur J Pharmacol 167:311–322
Mitchell SN, Smith KM, Joseph MH, Gray JA (1993) Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and nordrenaline release. Neuroscience 56:989–997
Morris RGM, Garrud P, Rawlins JNP, O'Keefe J (1982) Place navigation is impaired in rats with hippocampal lesions. Nature 297:681–683
Nordberg A, Romanelli L, Sundwall A, Bianchi C, Beani L (1989) Effects of acute and subchronic nicotine treatment on cortical acetylcholine release and on nicotinic receptors following continuous infusion of nicotine is brain-region-specific. Brain Res 617:349–352
Owen S, Boarder M, Gray JA, Fillenz M (1982) Acquisition and extinction of continuously and partially reinforced running in rats with lesions of the dorsal noradrenergic bundle. Behav Brain Res 5:11–41
Pauly JR, Marks MJ, Gross SD, Collins AC (1991) An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther 258:1127–1136
Peeke SC, Peeke HVS (1984) Attention, memory, and cigarette smoking. Psychopharmacology 84:205–216
Peng X, Gerzanich V, Anand R, Whiting PJ, Lindstrom J (1994) Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol 46:523–530
Plowchalk DR, Andersen ME, DeBethizy JD (1992) A physiologically based pharmacokinetic model for nicotine disposition in the Sprague-Dawley rat. Toxicol Appl Pharmacol 116:177–188
Poincheval-Fuhrman S, Sara SJ (1993) Chronic nicotine ingestion improves radial arm maze performance in rats. Behav Pharmacol 4:535–539
Provost SC, Woodward R (1991) Effects of nicotine gum on repeated administration of the Stroop test. Psychopharmacology 104:536–540
Ramoa AS, Alkondon M, Aracava Y, Irons J, Lunt GG, (1990) The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther 254:71–82
Romm E, Lippiello PM, Marks MJ, Collins AC (1990) Purification of L-[3H]-nicotine eliminates low affinity binding. Life Sci 46:935–945
Rowell PR, Winkler DL (1984) Nicotine stimulation of [3H]-acetylcholine release from cerebral cortex synaptosomes. J Neurochem 43:1593–1598
Rowell RP, Carr LA, Garner AC (1987) Stimulation of [3H]-dopamine release by nicotine in rat nucleus accumbens. J Neurochem 49:1449–1454
Sanderson EM, Drasdo AL, McCrea K, Wonnacott S (1993) Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region specific. Brain Res 617:349–352
Schwartz RD, Kellar KJ (1983) Nicotinic cholinergic receptor binding sites in the brain: Regulation in vivo. Science 220:214–216
Schwartz RD, Kellar KJ (1985) In vivo regulation of [3H]-acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 45:427–433
Snell LD, Johnson KM (1989) Effects of nicotinic agonists and antagonists on N-methyl-d-aspartate-induced 3H-norepinephrine release and 3H-(1-[2-thienyl)-cyclohexyl]-piperidine) binding in rat hippocampus. Synapse 3:125–139
Summers W, Majovski L, Marsh G, Tachiki K, Kling A (1986) Oral tetrahydroaminoacridine in long term treatment of senile dementia, Alzheimer type. N Engl J Med 315:239–245
Sunderland T, Tariot P, Mueller E, Murphy D, Weingartner H, Cohen R (1985) Pharmacological challenge strategies in Alzheimer's disease: basic and clinical issues. Psychopharmacol Bull 21:676–679
Sutherland RJ, Whishaw IQ, Kolb B (1983) A behavioral analysis of spatial localization following electrolytic, kainate- or colchicine-induced damage to the hippocampal formation in the rat. Behav Brain Res 7:133–153
Warburton DM (1992) Nicotine as a cognitive enhancer. Prog Neuropsychopharmacol Biol Psychiatry 16:181–199
Wesnes K, Warburton DM (1978) Effects of cigarette smoking and nicotine tablets upon human attention. In: Thornton RE (ed) Smoking behaviour: physiological and psychological influences. Churchill Livingstone, Edinburgh, pp 131–147
Wesnes K, Warburton DM (1983) Smoking, nicotine and human performance. Pharmacol Ther 21:189–208
West R, Hack S (1991) Effect of cigarettes on memory search and subjective ratings. Pharmacol Biochem Behav 38:281–286
Whiting P, Esch F, Shimasaki, D, Lindstrom J (1987) Neuronal nicotinic acetylcholine receptor β-subunit is coded for by the cDNA clone α4. FEBS Lett 219:459–463
Wonnacott S (1990) The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11:216–219
Wonnacott S, Irons J, Rapier C, Thorne B, Lunt GG (1989) Presynaptic modulation of transmitter release by nicotinic receptors. In: Nordberg A, Fuxe K, Holmstedt B, Sundwall A (eds) Progress in brain research. Elsevier, Amsterdam, pp 157–163
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abdulla, F.A., Gray, J.A., Sinden, J.D. et al. Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation. Psychopharmacology 124, 323–331 (1996). https://doi.org/10.1007/BF02247437
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02247437